Copyright
©The Author(s) 2023.
World J Clin Cases. Jan 6, 2023; 11(1): 104-115
Published online Jan 6, 2023. doi: 10.12998/wjcc.v11.i1.104
Published online Jan 6, 2023. doi: 10.12998/wjcc.v11.i1.104
Variable | N | Percentage (%) | |
Commenced on | Yes | 262 | 100.0 |
1st mo WT (kg) | 1-7 | 23 | 8.8 |
8-15 | 170 | 65.4 | |
16-23 | 66 | 25.4 | |
24-31 | 1 | 0.4 | |
1st mo Dose | < 100 mg | 106 | 40.5 |
150-200 mg | 153 | 58.4 | |
250 mg and above | 3 | 1.1 | |
2nd mo WT (kg) | 1-7 | 23 | 11.4 |
8-15 | 122 | 60.4 | |
16-23 | 56 | 27.7 | |
24-31 | 1 | 0.5 | |
2nd mo Dose | < 100 mg | 87 | 41.4 |
150-200 mg | 121 | 57.6 | |
250 mg and above | 2 | 1.0 | |
3rd mo WT (kg) | 1-7 | 15 | 7.9 |
8-15 | 105 | 55.3 | |
16-23 | 69 | 36.3 | |
24-31 | 1 | 0.5 | |
3rd mo Dose | < 100 mg | 75 | 39.9 |
150-200 mg | 111 | 59.0 | |
250 mg and above | 2 | 1.1 | |
4th mo WT (kg) | 1-7 | 12 | 7.3 |
8-15 | 92 | 55.8 | |
16-23 | 57 | 34.5 | |
24-31 | 4 | 2.4 | |
4th mo Dose | < 100 mg | 67 | 38.5 |
150-200 mg | 106 | 60.9 | |
250 mg and above | 1 | 0.6 | |
5th mo WT (kg) | 1-7 | 10 | 6.3 |
8-15 | 91 | 57.2 | |
16-23 | 53 | 33.3 | |
24-31 | 5 | 3.1 | |
5th mo Dose | < 100 mg | 62 | 38.3 |
150-200 mg | 99 | 61.1 | |
250 mg and above | 1 | 0.6 | |
6th mo WT (kg) | 1-7 | 6 | 4.1 |
8-15 | 79 | 54.1 | |
16-23 | 56 | 38.4 | |
24-31 | 5 | 3.4 | |
6th mo Dose | < 100 mg | 55 | 35.5 |
150-200 mg | 99 | 63.9 | |
250 mg and above | 1 | 0.6 |
Treatment Outcome | |||||||
Completed | Loss to follow up | Total | χ2 | DF | P value | ||
Gender | Male | 88 (33.6) | 53 (20.2) | 141 (53.8) | 1.336 | 1 | 0.248 |
Female | 67 (25.6) | 54 (20.6) | 121 (46.2) | ||||
Total | 155 (59.2) | 107 (40.8) | 262 (100.0) | ||||
Age | 0-24 | 57 (55.3) | 46 (44.7) | 103 (40.2) | 4.114 | 2 | 0.128 |
25-48 | 62 (68.1) | 29 (31.9) | 91 (35.5) | ||||
49 and above | 34 (54.8) | 28 (45.2) | 62 (24.2) | ||||
Total | 153 (59.8) | 103 (40.2) | 256 (100.0) | ||||
Type of facility | PFP | 103 (39.3) | 70 (26.7) | 173 (66.0) | 0.030 | 1 | 0.862 |
PNFP | 52 (19.8) | 37 (14.1) | 89 (34.0) | ||||
Total | 155 (59.2) | 107 (40.8) | 262 (100.0) |
- Citation: Adepoju VA, Adelekan A, Agbaje A, Quaitey F, Ademola-Kay T, Udoekpo AU, Sokoya OD. Completion of 6-mo isoniazid preventive treatment among eligible under six children: A cross-sectional study, Lagos, Nigeria. World J Clin Cases 2023; 11(1): 104-115
- URL: https://www.wjgnet.com/2307-8960/full/v11/i1/104.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i1.104